Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Hyperfine (HYPR) Research & Development (2021 - 2025)

Hyperfine (HYPR) has disclosed Research & Development for 5 consecutive years, with $4.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development fell 30.98% year-over-year to $4.0 million, compared with a TTM value of $18.7 million through Sep 2025, down 19.8%, and an annual FY2024 reading of $22.5 million, changed 0.03% over the prior year.
  • Research & Development was $4.0 million for Q3 2025 at Hyperfine, down from $4.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $8.9 million in Q4 2021 and bottomed at $4.0 million in Q3 2025.
  • Average Research & Development over 5 years is $5.9 million, with a median of $5.7 million recorded in 2023.
  • Peak annual rise in Research & Development hit 86.28% in 2022, while the deepest fall reached 41.31% in 2022.
  • Year by year, Research & Development stood at $8.9 million in 2021, then crashed by 41.31% to $5.2 million in 2022, then grew by 14.24% to $6.0 million in 2023, then dropped by 14.37% to $5.1 million in 2024, then fell by 20.71% to $4.0 million in 2025.
  • Business Quant data shows Research & Development for HYPR at $4.0 million in Q3 2025, $4.5 million in Q2 2025, and $5.0 million in Q1 2025.